LAVA Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LVTX and other ETFs, options, and stocks.

About LVTX

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands. 

CEO
Stephen Allen Hurly
CEOStephen Allen Hurly
Employees
37
Employees37
Headquarters
Utrecht, Noord-Brabant
HeadquartersUtrecht, Noord-Brabant
Founded
2016
Founded2016
Employees
37
Employees37

LVTX Key Statistics

Market cap
76.90M
Market cap76.90M
Price-Earnings ratio
-1.85
Price-Earnings ratio-1.85
Dividend yield
—
Dividend yield—
Average volume
230.60K
Average volume230.60K
High today
$3.08
High today$3.08
Low today
$2.88
Low today$2.88
Open price
$2.88
Open price$2.88
Volume
59.53K
Volume59.53K
52 Week high
$6.47
52 Week high$6.47
52 Week low
$1.13
52 Week low$1.13
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.